Akums Drugs & Pharmaceuticals Share Price
758.90-21.65 (-2.77%)
+60.09% past 1 Year
News
Akums Drugs And Pharmaceuticals to host analyst and investor meeting on September 2
Equity
AKUMS
Akums Drugs gains as Citi raises FY27–28 EPS estimates on CDMO, API outlook
Equity
AKUMS
Akums Drugs updates Baddi facility to expand oral manufacturing capacity by FY27
Equity
AKUMS
Akums Drugs updates API segment profitability target for FY27 and FY28
Equity
AKUMS
Akums Drugs shares update on Zambia order and Europe launch timeline
Equity
AKUMS
Akums Drugs sees improved domestic branded performance from Q3 FY27
Equity
AKUMS
Akums Drugs guides annual margins at 14% to 15% after strong Q1
Equity
AKUMS
Akums Drugs expects robust FY27 operating performance, CDMO growth stays strong
Equity
AKUMS
Akums Drugs outlines medium-term effective tax roadmap in recent concall update
Equity
AKUMS
Akums Drugs outlines Rs 300 crores capex plan for FY27 expansion
Equity
AKUMS
Akums Drugs sees trade generics business stable, limited impact on group performance
Equity
AKUMS
Akums Drugs guided for reduced API segment losses, targeting positive monthly EBITDA
Equity
AKUMS
Akums Drugs targets double digit growth in domestic branded formulations
Equity
AKUMS
Akums Drugs secures long term European CDMO contract with fixed pricing till 2032
Equity
AKUMS
Akums Drugs announces Zambia CDMO contract with phased FY27-FY28 supplies
Equity
AKUMS
Akums Drugs sees strong H1 FY27 CDMO volume growth with stable margins
Equity
AKUMS
Akums Drugs and Pharmaceuticals inform about update on disruption in operations
Equity
AKUMS
Akums Drugs resumes Haridwar manufacturing; four-day halt delays Rs 20 crore supply
Equity
AKUMS
Akums Drugs & Pharma - Quaterly Results
Equity
AKUMS
Akums Drugs and Pharmaceuticals informs about disruption in operations
Equity
AKUMS